AIIMS has validated the Swaasa AI app, which analyzes cough sounds to screen for respiratory conditions such as COPD, asthma, and tuberculosis. The non-invasive tool, already deployed in rural areas, offers rapid, affordable screening and was recognized among the top 10 Indian innovations at the AI Impact Summit 2026.
Health & Innovation Update
India’s healthcare sector is witnessing a breakthrough with the Swaasa AI app, developed by a Karnataka-based startup and validated by AIIMS New Delhi. The app records a patient’s cough and uses machine learning models to detect potential lung disorders within minutes.
This innovation is particularly impactful in rural and underserved areas, where access to spirometry and specialized diagnostics is limited. By offering a non-invasive, rapid, and cost-effective screening method, Swaasa bridges a critical gap in India’s primary healthcare system.
The app has been listed among the top 10 high-impact Indian innovations at the AI Impact Summit 2026, underscoring its potential to transform respiratory healthcare nationwide.
Key Highlights
-
Technology: AI-powered cough sound analysis.
-
Conditions Detected: COPD, asthma, pulmonary tuberculosis.
-
Validation: Extensive trials at AIIMS New Delhi.
-
Accessibility: Already in use in rural healthcare setups.
-
Recognition: Featured at AI Impact Summit 2026.
-
Impact: Affordable, rapid screening tool for lung health.
Sources: The Indian Express, The Economic Times, News18